60 mg of CBD per softgel is the planned label amount.
Each released lot will be tested against its controlled specification.
Micelle 60 is a hemp-derived CBD isolate softgel in development for participating care organizations. The planned label amount is 60 mg per softgel, and each bottle is planned to hold 60 softgels.
Product
Each released lot will be tested against its controlled specification.
A tightly specified ingredient with controlled impurities.
CBD does not dissolve well in water. A lipid-based softgel carries it.
An independent lab will test identity, potency, purity, and quality. Results will be published for each released lot.
Product facts
These four facts identify the product and connect a bottle to its lot record. Composition and release-dependent detail stay in the development specification.
All other composition and release-dependent details remain in the development specification below.
View label draft v1Development specification
Each line shows its current status. Everything moves to the label when confirmed.
The science inside
CBD dissolves well in fat but barely in water. Micelle 60 is being developed as a lipid-based softgel. The mix is designed to form small shapes called micelles in fluid. This gives the product its name.

The planned label amount is 60 mg of CBD in a lipid-based formulation.
CBD sits in a clear, lipid-based liquid inside the shell.
The formulation is designed to disperse into smaller structures on contact with fluid.
The illustration shows small structures around a CBD-containing center. Their size and shape can vary.
The lot record is where measured CBD, total THC per container, test methods, and status are published. The formulation is still in development.
Example measured dataConceptual illustration only. Size, arrangement, and particle form are illustrative, not measured; this does not show what happens in a person.
Purity and quality
Micelle 60 is being developed with high-purity CBD isolate. The isolate has a defined specification. Each finished-product lot will be tested before release for cannabinoid identity, potency, related substances, and quality. Each finished-product certificate will have its own lot page with the first released lot.
A hemp-derived CBD isolate softgel in development, with a planned label amount of 60 mg per softgel.
Packaging
The bottle, label, and softgel are still being designed. The label will show the lot number and expiry date. They link the bottle to its results.
If anything looks wrong, do not use it. Tell your care team.
They link the bottle to its results online.
It will open the matching lot page. It will not replace the printed lot number.
Documents
Questions
Micelle 60 is a hemp-derived CBD isolate softgel in development, with a planned label amount of 60 mg per softgel. Each bottle is planned to hold 60 softgels. The final ingredient list and release details remain pending controlled evidence.
A micelle is a small form that can appear in fluid. The images show its design. They do not show a result in a person.
Micelle 60 is in development, to be supplied only through participating care organizations. It is not offered for retail sale.
If Micelle 60 is released and your care organization takes part, your doctor would decide with you whether it fits your plan.
Medicare does not pay for the product.
Each released lot will be tested, and its lot page will list total THC per container with the test method. The planned finished-product target is less than 0.4 mg combined total THC, including THCA, across the full container. The broader federal finished-product restriction begins December 11, 2026. That threshold alone does not establish product compliance, approval, release, or CMS eligibility.
Products containing any THC may affect a drug test; tell your doctor before you start if you are tested.
After release, find the lot number on the label, enter it on the Quality page or scan the code, then read that lot’s results, certificate status, and notices. Example records are available now to demonstrate the planned format.
For anything about your health, contact your care team. To report a product concern today, use the phone or correspondence route on the product-concern page. In an emergency, call 911.